Skip to main content
. 2019 Nov 16;301(2):517–523. doi: 10.1007/s00404-019-05366-8

Table 1.

Subjects’ characteristics at baseline

Parameter Ze 450 (N = 32) MHT (N = 142) p value
n Median [lq, uq] or n (%) n Median [lq, uq] or n (%)
Age (years) 32 53.0 [48.5, 55.0] 142 52.0 [47.0, 55.0] 0.93
Body mass index (kg/m2) 31 24.5 [22.7, 27.4] 136 24.1 [21.2, 28.6] 0.68
Waist circumference (cm) 26 85.0 [79.0, 102.0] 122 88.0 [79.0, 96.0] 0.79
Systolic blood pressure (mmHg) 31 120 [112, 135] 138 120 [112, 130] 0.50
Diastolic blood pressure (mmHg) 31 80.0 [75.0, 88.0] 138 80.0 [70.0, 84.0] 0.13
Age at menarche (years) 31 14.0 [13.0, 15.0] 134 13.0 [12.0, 15.0] 0.16
Cycle length (days) 9 28.0 [28.0, 29.0] 24 28.0 [26.5, 28.0] 0.36
Age at menopause (years) 18 49.5 [45.0, 53.0] 67 48.0 [42.0, 51.0] 0.14
Time since last menstruation (years) 29 2.40 [0.47, 10.54] 124 2.42 [0.28, 8.44] 0.75
Reproductive stage according to STRAW + 10 [15] 29 121 0.038
 Premenopause 1 (3%) 21 (17%)
 Early menopausal transition 2 (7%) 23 (19%)
 Late menopausal transition 2 (7%) 11 (9%)
 Postmenopause 24 (83%) 66 (55%)
Smoking 32 142 0.09
 Never 18 (56%) 102 (72%)
 Currently 8 (25%) 30 (21%)
 In the past 6 (19%) 10 (7%)
Alcohol 32 142 0.67
 Never 16 (50%) 59 (42%)
 Regularly 6 (19%) 27 (19%)
 From time to time 10 (31%) 56 (39%)
AGLA® 10-year risk for fatal and non-fatal coronary heart disease (%) 21 0.70 [0.50, 1.20] 89 0.40 [0.20, 1.20] 0.12
FRAX® 10-year risk for osteoporotic fractures (%) 29 5.70 [4.40, 7.00] 127 5.60 [4.10, 7.10] 0.68
GAIL® 5-year risk for breast cancer (%) 31 1.30 [1.20, 1.50] 137 1.40 [1.10, 1.90] 0.22

N total number of observations, n number of non-missing observations